|
1
|
Wikner J, Gröbe A, Pantel K and Riethdorf
S: Squamous cell carcinoma of the oral cavity and circulating tumor
cells. World J Clin Oncol. 5:114–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mascitti M, Orsini G, Tosco V,
Monterubbianesi R, Balercia A, Putignano A, Procaccini M and
Santarelli A: An overview on current non-invasive diagnostic
devices in oral oncology. Front Physiol. 9:15102018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amerik AY and Hochstrasser M: Mechanism
and function of deubiquitinating enzymes. Biochim Biophys Acta.
1695:189–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang XY, Pfeiffer HK, Thorne AW and
McMahon SB: USP22, an hSAGA subunit and potential cancer stem cell
marker, reverses the polycomb-catalyzed ubiquitylation of histone
H2A. Cell Cycle. 7:1522–1524. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang XY, Varthi M, Sykes SM, Phillips C,
Warzecha C, Zhu W, Wyce A, Thorne AW, Berger SL and McMahon SB: The
putative cancer stem cell marker USP22 is a subunit of the human
SAGA complex required for activated transcription and cell-cycle
progression. Mol Cell. 29:102–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jordan CT: Cancer stem cell biology: From
leukemia to solid tumors. Curr Opin Cell Biol. 16:708–712. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang B, Liang X, Tang F, Zhang J, Zeng S,
Jin S, Zhou L, Kudo Y and Qi G: Expression of USP22 and survivin is
an indicator of malignant behavior in hepatocellular carcinoma. Int
J Oncol. 47:2208–2216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee HJ, Kim MS, Shin JM, Park TJ, Chung HM
and Baek KH: The expression patterns of deubiquitinating enzymes,
USP22 and Usp22. Gene Expr Patterns. 6:277–284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Glinsky GV, Berezovska O and Glinskii AB:
Microarray analysis identifies a death-from-cancer signature
predicting therapy failure in patients with multiple types of
cancer. J Clin Invest. 115:1503–1521. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv L, Xiao XY, Gu ZH, Zeng FQ, Huang LQ
and Jiang GS: Silencing USP22 by asymmetric structure of
interfering RNA inhibits proliferation and induces cell cycle
arrest in bladder cancer cells. Mol Cell Biochem. 346:11–21. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu YL, Yang YM, Xu H and Dong XS:
Aberrant expression of USP22 is associated with liver metastasis
and poor prognosis of colorectal cancer. J Surg Oncol. 103:283–289.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo Y, Zeng FQ, Gu ZH, Wang L, Wang ZY,
Jiang GS and Xiao XY: Quantitative analysis of the putative cancer
stem cell marker USP22 mRNA in the transitional cell carcinoma of
the bladder and the relationship between USP22 and the grading of
tumor. J Clin Urol. 24:140–144. 2009.
|
|
13
|
Carmena M, Wheelock M, Funabiki H and
Earnshaw WC: The chromosomal passenger complex (CPC): From easy
rider to the godfather of mitosis. Nat Rev Mol Cell Biol.
13:789–803. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van der Waal MS, Hengeveld RC, van der
Horst A and Lens SM: Cell division control by the chromosomal
passenger complex. Exp Cell Res. 318:1407–1420. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Altieri DC: Validating survivin as a
cancer therapeutic target. Nat Rev Cancer. 3:46–54. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vong QP, Cao K, Li HY, Iglesias PA and
Zheng Y: Chromosome alignment and segregation regulated by
ubiquitination of survivin. Science. 310:1499–1504. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Lang G, Ito S, Bonnet J, Metzger
E, Sawatsubashi S, Suzuki E, Le Guezennec X, Stunnenberg HG,
Krasnov A, et al: A TFTC/STAGA module mediates histone H2A and H2B
deubiquitination, coactivates nuclear receptors, and counteracts
heterochromatin silencing. Mol Cell. 29:92–101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Z, Hu S, Luo Q, Ye D, Hu D and Chen F:
Overexpression of SENP3 in oral squamous cell carcinoma and its
association with differentiation. Oncol Rep. 29:1701–1706. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: Pathology and genetics of head and neck tumours. IARC
Press. World Health Organization Classification of Tumours.
168–175. 2005.
|
|
20
|
Liu YL, Zheng J, Tang LJ, Han W, Wang JM,
Liu DW and Tian QB: The deubiquitinating enzyme activity of USP22
is necessary for regulating HeLa cell growth. Gene. 572:49–56.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maerki S, Olma MH, Staubli T, Steigemann
P, Gerlich DW, Quadroni M, Sumara I and Peter M: The Cul3-KLHL21 E3
ubiquitin ligase targets aurora B to midzone microtubules in
anaphase and is required for cytokinesis. J Cell Biol. 187:791–800.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi G, Tuncel H, Aoki E, Tanaka S, Oka S,
Kaneko I, Okamoto M, Tatsuka M, Nakai S and Shimamoto F:
Intracellular localization of survivin determines biological
behavior in colorectal cancer. Oncol Rep. 22:557–562.
2009.PubMed/NCBI
|
|
23
|
Qi G, Kudo Y, Ando T, Tsunematsu T,
Shimizu N, Siriwardena SB, Yoshida M, Keikhaee MR, Ogawa I and
Takata T: Nuclear Survivin expression is correlated with malignant
behaviors of head and neck cancer together with Aurora-B. Oral
Oncol. 46:263–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tuncel H, Shimamoto F, Kaneko Guangying Qi
H, Aoki E, Jikihara H, Nakai S, Takata T and Tatsuka M: Nuclear
Aurora B and cytoplasmic Survivin expression is involved in lymph
node metastasis of colorectal cancer. Oncol Lett. 3:1109–1114.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hori M, Miki T, Okamoto M, Yazama F,
Konishi H, Kaneko H, Shimamoto F, Ota T, Temme A and Tatsuka M: The
detergent-soluble cytoplasmic pool of survivin suppresses anoikis
and its expression is associated with metastatic disease of human
colon cancer. PLoS One. 8:e557102013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi G, Ogawa I, Kudo Y, Miyauchi M,
Siriwardena BS, Shimamoto F, Tatsuka M and Takata T: Aurora-B
expression and its correlation with cell proliferation and
metastasis in oral cancer. Virchows Arch. 450:297–302. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qi G, Mi S, Jin S, Shao W, Liu J, Liu T,
Zeng S and Lu H: The role of the cancer stem cell marker USP22 in
tumors. Stem Cell Trans Invest. 3:e12192016.
|
|
28
|
Kurai M, Shiozawa T, Shih HC, Miyamoto T,
Feng YZ, Kashima H, Suzuki A and Konishi I: Expression of Aurora
kinases A and B in normal, hyperplastic, and malignant human
endometrium: Aurora B as a predictor for poor prognosis in
endometrial carcinoma. Hum Pathol. 36:1281–1288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nguyen HG, Chinnappan D, Urano T and Ravid
K: Mechanism of Aurora-B degradation and its dependency on intact
KEN and A-boxes: Identification of an aneuploidy-promoting
property. Mol Cell Biol. 25:4977–4992. 2005. View Article : Google Scholar : PubMed/NCBI
|
